# Xtant Medical Holdings, Inc.: filings

XTNT · NYSE · CIK 1453593 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xtnt.md) · [Financials](/companies/xtnt/financials.md) · [Filings](/companies/xtnt/filings.md) · [Insiders](/companies/xtnt/insiders.md)

## Reports and events: 545 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 392, 4 267, 10-Q 51, 3 43, EFFECT 36, CORRESP 32, UPLOAD 27, SC 13G/A 23, S-1/A 20, POS AM 19, SC 13D/A 18, 10-K 17, DEF 14A 17, 424B3 11, S-1 10, S-8 10, D 9, S-3 9, SC 13G 9, S-8 POS 8, 8-K/A 7, FWP 7, 4/A 6, SC 13D 5, ARS 4, PRE 14A 4, 10-Q/A 3, 3/A 3, NT 10-Q 3, 10-K/A 2, 424B2 2, 424B5 2, 8-A12B 2, 8-A12B/A 2, CERTNYS 2, DEF 14C 2, DEFA14A 2, PRE 14C 2, SCHEDULE 13D/A 2, SCHEDULE 13G 2, SD 2, 25-NSE 1, 424B1 1, 424B4 1, D/A 1, DEFR14A 1, DEL AM 1, NT 10-K 1, PRER14A 1, S-3/A 1, SCHEDULE 13D 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-11 | 07:15 ET | [10-Q](/filings/0001493152-26-036981.md) | Quarterly report, period 2026-06-30 | 0001493152-26-036981 |
| 2026-08-11 | 07:05 ET | [8-K](/filings/0001493152-26-036979.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-036979 |
| 2026-08-07 | 16:15 ET | [8-K](/filings/0001493152-26-036586.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-036586 |
| 2026-06-23 | 07:00 ET | [DEF 14A](/filings/0001493152-26-029699.md) | Proxy statement, period 2026-06-23 | 0001493152-26-029699 |
| 2026-05-13 | 07:15 ET | [10-Q](/filings/0001493152-26-022604.md) | Quarterly report, period 2026-03-31 | 0001493152-26-022604 |
| 2026-05-13 | 07:05 ET | [8-K](/filings/0001493152-26-022600.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-022600 |
| 2026-04-13 | 09:20 ET | [8-K](/filings/0001493152-26-016308.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-016308 |
| 2026-03-31 | 07:16 ET | [10-K](/filings/0001493152-26-013792.md) | Annual report, period 2025-12-31 | 0001493152-26-013792 |
| 2026-03-31 | 07:05 ET | [8-K](/filings/0001493152-26-013788.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-013788 |
| 2026-03-02 | 08:15 ET | [8-K](/filings/0001493152-26-008453.md) | 8.01 Other events | 0001493152-26-008453 |
| 2026-01-16 | 16:15 ET | [8-K](/filings/0001493152-26-002569.md) | 8.01 Other events | 0001493152-26-002569 |
| 2025-12-03 | 16:05 ET | [8-K](/filings/0001493152-25-025963.md) | 2.01 Completion of an acquisition or disposition; 2.04 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-025963 |
| 2025-11-10 | 16:46 ET | [8-K](/filings/0001493152-25-021538.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-021538 |
| 2025-11-10 | 16:11 ET | [10-Q](/filings/0001493152-25-021512.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021512 |
| 2025-11-10 | 07:00 ET | [8-K](/filings/0001493152-25-021389.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-021389 |
| 2025-09-15 | 06:28 ET | [DEF 14A](/filings/0001493152-25-013361.md) | Proxy statement, period 2025-09-15 | 0001493152-25-013361 |
| 2025-08-12 | 08:50 ET | [10-Q](/filings/0001641172-25-023120.md) | Quarterly report, period 2025-06-30 | 0001641172-25-023120 |
| 2025-08-12 | 07:51 ET | [8-K](/filings/0001641172-25-023109.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-023109 |
| 2025-08-08 | 16:15 ET | [8-K](/filings/0001641172-25-022762.md) | 8.01 Other events | 0001641172-25-022762 |
| 2025-08-05 | 16:30 ET | [SCHEDULE 13D/A](/filings/0001104659-25-074220.md) | Ownership report, active investor, amended | 0001104659-25-074220 |
| 2025-08-04 | 09:00 ET | [8-K](/filings/0001641172-25-022002.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-022002 |
| 2025-07-08 | 08:10 ET | [8-K](/filings/0001641172-25-018092.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-018092 |
| 2025-05-12 | 16:52 ET | [S-1](/filings/0001641172-25-009734.md) | Registration statement | 0001641172-25-009734 |
| 2025-05-12 | 16:05 ET | [10-Q](/filings/0001641172-25-009674.md) | Quarterly report, period 2025-03-31 | 0001641172-25-009674 |
| 2025-05-12 | 16:01 ET | [8-K](/filings/0001641172-25-009664.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009664 |
| 2025-04-17 | 16:31 ET | [SCHEDULE 13D](/filings/0001104659-25-036047.md) | Ownership report, active investor | 0001104659-25-036047 |
| 2025-04-16 | 16:55 ET | [8-K](/filings/0001641172-25-005078.md) | 1.02 Termination of a material agreement; 2.02 Results of operations; 5.01 Change in control; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-005078 |
| 2025-04-14 | 19:09 ET | [SCHEDULE 13D/A](/filings/0000947871-25-000391.md) | Ownership report, active investor, amended | 0000947871-25-000391 |
| 2025-04-11 | 07:00 ET | [8-K](/filings/0001641172-25-003711.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-003711 |
| 2025-03-06 | 16:16 ET | [10-K](/filings/0001493152-25-009391.md) | Annual report, period 2024-12-31 | 0001493152-25-009391 |
| 2025-03-06 | 16:10 ET | [8-K](/filings/0001493152-25-009386.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-009386 |
| 2024-11-12 | 16:15 ET | [10-Q](/filings/0001493152-24-044764.md) | Quarterly report, period 2024-09-30 | 0001493152-24-044764 |
| 2024-11-12 | 16:10 ET | [8-K](/filings/0001493152-24-044756.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-044756 |
| 2024-09-10 | 16:12 ET | [SC 13D/A](/filings/0000947871-24-000749.md) | Ownership report, active investor, amended | 0000947871-24-000749 |
| 2024-09-03 | 16:05 ET | [8-K](/filings/0001493152-24-034813.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-034813 |
| 2024-08-08 | 07:30 ET | [8-K](/filings/0001493152-24-030667.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-030667 |
| 2024-08-08 | 07:25 ET | [10-Q](/filings/0001493152-24-030663.md) | Quarterly report, period 2024-06-30 | 0001493152-24-030663 |
| 2024-08-08 | 07:20 ET | [8-K](/filings/0001493152-24-030662.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-030662 |
| 2024-07-24 | 16:15 ET | [8-K](/filings/0001493152-24-028920.md) | 5.07 Shareholder vote results | 0001493152-24-028920 |
| 2024-06-10 | 07:00 ET | [DEF 14A](/filings/0001493152-24-023268.md) | Proxy statement, period 2024-06-10 | 0001493152-24-023268 |
| 2024-05-15 | 16:20 ET | [10-Q](/filings/0001493152-24-019887.md) | Quarterly report, period 2024-03-31 | 0001493152-24-019887 |
| 2024-05-15 | 16:15 ET | [8-K](/filings/0001493152-24-019864.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-019864 |
| 2024-04-01 | 07:10 ET | [10-K](/filings/0001493152-24-012145.md) | Annual report, period 2023-12-31 | 0001493152-24-012145 |
| 2024-04-01 | 07:05 ET | [8-K](/filings/0001493152-24-012143.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-012143 |
| 2024-03-07 | 17:13 ET | [8-K](/filings/0001493152-24-009247.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-009247 |
| 2023-11-14 | 16:06 ET | [10-Q](/filings/0001493152-23-041077.md) | Quarterly report, period 2023-09-30 | 0001493152-23-041077 |
| 2023-11-09 | 07:15 ET | [8-K](/filings/0001493152-23-039986.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-039986 |
| 2023-10-26 | 16:05 ET | [8-K/A](/filings/0001493152-23-038380.md) | 9.01 Financial statements and exhibits | 0001493152-23-038380 |
| 2023-10-23 | 17:00 ET | [8-K](/filings/0001493152-23-038003.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-038003 |
| 2023-08-18 | 16:15 ET | [8-K](/filings/0001493152-23-029442.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-23-029442 |

Page 1 of 11. [Older](/companies/xtnt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.